Precision Business Insights
Portfolio

 

Research Reports

Global Neurological Disorder Diagnostics Market : Market Estimation, Dynamics, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Neurological Disorder Diagnostics Market: By Technology (Imaging and In-Vitro Diagnostics), By Indication (Genetic Neurological Disorders, Immunological Neurological Disorders, Paraneoplastic Syndrome, Paraproteinemic Neuropathies, and Others), By End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Care Centers), and Geography

 

 

Global Neurological Disorder Diagnostics Market

 

Global Neurological Disorder Diagnostics Market Report Description:

Global neurological disorder diagnostics market report gives comprehensive outlook on neurological disorder diagnostics across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global neurological disorder diagnostics market gives historical, current, and future market sizes (US$ Mn) on the basis of technology, indication, end user, and region. This report studies global neurological disorder diagnostics market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global neurological disorder diagnostics market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global neurological disorder diagnostics market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global neurological disorder diagnostics market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global neurological disorder diagnostics products.

 

Global Neurological Disorder Diagnostics Market:

The global neurological disorder diagnostics market estimated to be valued US$ XX Mn in 2018 and poised to grow at significant CAGR over 2019-2025 owing to increasing prevalence of neurological problems that are caused by genetic disorders, congenital abnormalities, infections, lifestyle, environmental health problems including malnutrition, and brain injury, spinal cord injury etc. and launch of innovative products for diagnosis of disease and approvals for novel diagnostic products for neurological disorders are the major factors that are driving the growth of the neurological disorder diagnostics market. Moreover, rising adoption of biomarkers to diagnose various diseases fuels the growth of the market over the forecasted period. However, high cost of neurological diagnostic imaging tools such as MRI and CT scan are expected to restrain the growth of the market over the future years.

 

Increasing Adoption of Technology and Developments in Innovate Technologies

Currently, adoption of new technology among the population has been increased in past few decades. Additionally, market players are focusing on the development of novel technologies for neurological disorders to offer the advanced treatment options. For instance, For instance, Canon Medical Systems, Kumamoto University, and University of Bordeaux entered into collaborative research for the development of deep learning technology in magnetic resonance imaging. Increase in per capita healthcare expenditure and well develop healthcare infrastructure boosts the growth of the market over the forecast period.

 

North America Accounts for Larger Market Revenue Share in Global Neurological Disorder Diagnostics Market

North America accounted for larger revenue share in global neurological disorder diagnostics market with significant CAGR and is expected to grow over the forecast years owing to technological advancements in the region and presence of large number of market players and development and launch of new products enhances the growth of the market. Moreover, availability of healthcare reimbursements and well established healthcare infrastructure in the region drives the growth of the market. Europe and Asia Pacific market expected to grow at a faster growth rate owing to owing to increasing prevalence of neurological disorders in the region and rising awareness among the people about the availability of advanced medical treatments and improving healthcare infrastructure in the emerging countries of the region. Additionally, rising adoption of diagnostic devices by the hospitals and ambulatory surgical centers. For instance, Japan have over 100 CT scanners per 1,000,000 population. According to OECD, Japan had 107.2 CT scanners per 1,000,000 population in 2014.

 

Competition Assessment

Key player’s profiles in the global neurological disorder diagnostics market include:

  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • General Electric Company
  • Esaote SpA
  • NeuroLogica Corporation
  • Masimo Corporation
  • York Instruments Ltd.
  • Neusoft Medical Systems
  • Canon Medical Systems Corporation
  • Smith & Nephew Inc
  • Johnson & Johnson

 

Global neurological disorder diagnostics market is surging owing to product launches and approvals of novel neurological disorder by the market players and strategic collaborations and acquisitions among them to strengthen their position in the market. For instance, in April 2018, Canon Medical Systems Corporation launched 1.5T MRI System, Vantage Orian. In 2017, Neusoft Medical Systems received U.S. FDA approval for NeuViz Prime CT Scanner. In April 2018, Siemens Healthineers received U.S. FDA approval for its new SOMATOM go.All and SOMATOM go.Top computed tomography (CT) systems.

 

Key Findings of the Report:

 

  • Global neurological disorder diagnostics market expanding at significant CAGR over 2018 to 2024 owing to increasing prevalence of neurological disorders and rising adoption of new technologies
  • Based on technology, CT scan market accounted for larger market revenue share in 2018 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global neurological disorder diagnostics market

 

Key Features of the Report:

 

  • The report provides granular level information about the market size, regional market share, historic market (2014-2018) and forecast (2019-2025)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Detailed Segmentation

 

By Technology

  • Imaging
    • Computed Tomography (CT)
    • Magnetic Resonance Imaging (MRI)
    • Electroencephalography (EEG)
    • Single-Photon Emission Computed Tomography (SPECT)
    • Nuclear Medicine Imaging
    • Magnetoencephalography (MEG)
    • Positron Emission Tomography (PET)
    • Ultrasound Imaging
  • In-Vitro Diagnostics
    • Biomarker
    • Biopsy
    • Others

By Indication

  • Genetic Neurological Disorders
    • Alzheimer’s Disease (AD)
    • Parkinson’s Disease (PD)
    • Huntington’s Disease (HD)
    • Amyotrophic Lateral Sclerosis (ALS)
    • Others
  • In-Vitro Diagnostics
    • Multiple Sclerosis
    • Others
  • Paraneoplastic Syndrome
  • Paraproteinemic Neuropathies
  • Others

By End User

  • Hospitals and Clinics
  • Diagnostic Centers
  • Ambulatory Care Centers

Geography

 

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

  1. Executive Summary
  2. Global Neurological Disorder Diagnostics Market Introduction
    • Global Neurological Disorder Diagnostics Market – Taxonomy
    • Global Neurological Disorder Diagnostics Market –Definitions
      • By Technology
      • By Indication
      • By End User
      • By Region
  1. Global Neurological Disorder Diagnostics Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Neurological Disorder Diagnostics Market Dynamics – Factors Impact Analysis
  2. Global Neurological Disorder Diagnostics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Neurological Disorder Diagnostics Market Forecast, By Technology, 2014 – 2018 and Forecast, 2019 – 2025
    • Imaging
      • Computed Tomography (CT)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Magnetic Resonance Imaging (MRI)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Electroencephalography (EEG)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Single-Photon Emission Computed Tomography (SPECT)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Nuclear Medicine Imaging
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Magnetoencephalography (MEG)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Positron Emission Tomography (PET)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Ultrasound Imaging
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • In-Vitro Diagnostics
        • Biomarker
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Biopsy
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Others
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
  1. Global Neurological Disorder Diagnostics Market Forecast, By Indication, 2014 – 2018 and Forecast, 2019 – 2025
    • Genetic Neurological Disorders
      • Alzheimer’s Disease (AD)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Parkinson’s Disease (PD)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Huntington’s Disease (HD)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Amyotrophic Lateral Sclerosis (ALS)
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Others
        • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Immunological Neurological Disorders
        • Multiple Sclerosis
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Others
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Paraneoplastic Syndrome
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Paraproteinemic Neuropathies
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Others
          • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
  1. Global Neurological Disorder Diagnostics Market Forecast, By End User, 2014 – 2018 and Forecast, 2019 – 2025
    • Hospitals & Clinics
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostic Centers
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ambulatory Care Centers
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Neurological Disorder Diagnostics Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025
    • North America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia Pacific
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • The Middle East & Africa
      • Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Technology, By Indication, By End User, and Region, 2019 – 2025
  2. North America Neurological Disorder Diagnostics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Technology Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Imaging
        • Computed Tomography (CT)
        • Magnetic Resonance Imaging (MRI)
        • Electroencephalography (EEG)
        • Single-Photon Emission Computed Tomography (SPECT)
        • Nuclear Medicine Imaging
        • Magnetoencephalography (MEG)
        • Positron Emission Tomography (PET)
        • Ultrasound Imaging
      • In-Vitro Diagnostics
        • Biomarker
        • Biopsy
        • Others
      • Indication Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Genetic Neurological Disorders
          • Alzheimer’s Disease (AD)
          • Parkinson’s Disease (PD)
          • Huntington’s Disease (HD)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Others
        • Immunological Neurological Disorders
          • Multiple Sclerosis
          • Others
        • Paraneoplastic Syndrome
        • Paraproteinemic Neuropathies
        • Others
      • End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Ambulatory Care Centers
      • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • US.
        • Canada
      • North America Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Technology, By Indication, By End User, and Country, 2019 – 2025
      • North America Neurological Disorder Diagnostics Market Dynamics – Trends
  1. Europe Neurological Disorder Diagnostics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Technology Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Imaging
        • Computed Tomography (CT)
        • Magnetic Resonance Imaging (MRI)
        • Electroencephalography (EEG)
        • Single-Photon Emission Computed Tomography (SPECT)
        • Nuclear Medicine Imaging
        • Magnetoencephalography (MEG)
        • Positron Emission Tomography (PET)
        • Ultrasound Imaging
      • In-Vitro Diagnostics
        • Biomarker
        • Biopsy
        • Others
      • Indication Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Genetic Neurological Disorders
          • Alzheimer’s Disease (AD)
          • Parkinson’s Disease (PD)
          • Huntington’s Disease (HD)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Others
        • Immunological Neurological Disorders
          • Multiple Sclerosis
          • Others
        • Paraneoplastic Syndrome
        • Paraproteinemic Neuropathies
        • Others
      • End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Ambulatory Care Centers
      • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • UK.
        • Germany
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
      • Europe Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Technology, By Indication, By End User, and Country, 2019 – 2025
      • Europe Neurological Disorder Diagnostics Market Dynamics – Trends
  1. Asia Pacific Neurological Disorder Diagnostics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Technology Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Imaging
        • Computed Tomography (CT)
        • Magnetic Resonance Imaging (MRI)
        • Electroencephalography (EEG)
        • Single-Photon Emission Computed Tomography (SPECT)
        • Nuclear Medicine Imaging
        • Magnetoencephalography (MEG)
        • Positron Emission Tomography (PET)
        • Ultrasound Imaging
      • In-Vitro Diagnostics
        • Biomarker
        • Biopsy
        • Others
      • Indication Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Genetic Neurological Disorders
          • Alzheimer’s Disease (AD)
          • Parkinson’s Disease (PD)
          • Huntington’s Disease (HD)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Others
        • Immunological Neurological Disorders
          • Multiple Sclerosis
          • Others
        • Paraneoplastic Syndrome
        • Paraproteinemic Neuropathies
        • Others
      • End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Ambulatory Care Centers
      • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • China
        • Japan
        • India
        • ASEAN Counties
        • Philippines
        • Rest of Asia Pacific
      • Asia Pacific Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Technology, By Indication, By End User, and Country, 2019 – 2025
      • Asia Pacific Neurological Disorder Diagnostics Market Dynamics – Trends
  1. Latin America Neurological Disorder Diagnostics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Technology Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Imaging
        • Computed Tomography (CT)
        • Magnetic Resonance Imaging (MRI)
        • Electroencephalography (EEG)
        • Single-Photon Emission Computed Tomography (SPECT)
        • Nuclear Medicine Imaging
        • Magnetoencephalography (MEG)
        • Positron Emission Tomography (PET)
        • Ultrasound Imaging
      • In-Vitro Diagnostics
        • Biomarker
        • Biopsy
        • Others
      • Indication Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Genetic Neurological Disorders
          • Alzheimer’s Disease (AD)
          • Parkinson’s Disease (PD)
          • Huntington’s Disease (HD)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Others
        • Immunological Neurological Disorders
          • Multiple Sclerosis
          • Others
        • Paraneoplastic Syndrome
        • Paraproteinemic Neuropathies
        • Others
      • End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Ambulatory Care Centers
      • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Mexico
        • Brazil
        • Argentina
        • Chile
        • Rest of Latin America
      • Latin America Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Technology, By Indication, By End User, and Country, 2019 – 2025
      • Latin America Neurological Disorder Diagnostics Market Dynamics – Trends
  1. Middle East and Africa Neurological Disorder Diagnostics Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
    • Technology Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Imaging
        • Computed Tomography (CT)
        • Magnetic Resonance Imaging (MRI)
        • Electroencephalography (EEG)
        • Single-Photon Emission Computed Tomography (SPECT)
        • Nuclear Medicine Imaging
        • Magnetoencephalography (MEG)
        • Positron Emission Tomography (PET)
        • Ultrasound Imaging
      • In-Vitro Diagnostics
        • Biomarker
        • Biopsy
        • Others
      • Indication Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Genetic Neurological Disorders
          • Alzheimer’s Disease (AD)
          • Parkinson’s Disease (PD)
          • Huntington’s Disease (HD)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Others
        • Immunological Neurological Disorders
          • Multiple Sclerosis
          • Others
        • Paraneoplastic Syndrome
        • Paraproteinemic Neuropathies
        • Others
      • End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Ambulatory Care Centers
      • Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • GCC Countries
        • South Africa
        • Saudi Arabia
        • Turkey
        • Rest of MEA
      • Middle East and Africa Neurological Disorder Diagnostics Market – Opportunity Analysis Index, By Technology, By Indication, By End User, and Country, 2019 – 2025
      • Middle East and Africa Neurological Disorder Diagnostics Market Dynamics – Trends
  1. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)
      • Siemens Healthineers
      • Koninklijke Philips N.V.
      • General Electric Company
      • Esaote SpA
      • NeuroLogica Corporation
      • Masimo Corporation
      • York Instruments Ltd.
      • Neusoft Medical Systems
      • Canon Medical Systems Corporation
      • Smith & Nephew Inc
      • Johnson & Johnson
  1. Research End Userology
  2. Key Assumptions and Acronyms
$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials